Cargando…
Cerebrospinal fluid from Alzheimer’s disease patients as an optimal formulation for therapeutic application of mesenchymal stem cells in Alzheimer’s disease
Mesenchymal stem cells (MSCs) have emerged as one of the promising treatment options for Alzheimer’s disease (AD). Although many studies have investigated on the efficacy of MSCs in AD, how MSCs actually change following exposure to the AD environment has not been studied extensively. In this study,...
Autores principales: | Lee, Jeongmin, Kwon, Soo Jin, Kim, Jang Hoon, Jang, Hyemin, Lee, Na Kyung, Hwang, Jung Won, Kim, Jong Hwa, Chang, Jong Wook, Na, Duk L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6346116/ https://www.ncbi.nlm.nih.gov/pubmed/30679696 http://dx.doi.org/10.1038/s41598-018-37252-9 |
Ejemplares similares
-
Cerebrospinal Fluid Biomarkers for the Diagnosis and Classification of Alzheimer's Disease Spectrum
por: Lee, Jongmin, et al.
Publicado: (2020) -
Agouti Related Peptide Secreted Via Human Mesenchymal Stem Cells Upregulates Proteasome Activity in an Alzheimer’s Disease Model
por: Lee, Na Kyung, et al.
Publicado: (2017) -
Combination of Dexamethasone and Tofacitinib Reduces Xenogeneic MSC-Induced Immune Responses in a Mouse Model of Alzheimer’s Disease
por: Lee, Na Kyung, et al.
Publicado: (2022) -
Identification of potential biomarkers related to mesenchymal stem cell response in patients with Alzheimer’s disease
por: Choi, Yejoo, et al.
Publicado: (2023) -
Intra-Arterially Delivered Mesenchymal Stem Cells Are Not Detected in the Brain Parenchyma in an Alzheimer’s Disease Mouse Model
por: Lee, Na Kyung, et al.
Publicado: (2016)